Jason Mark Summa

age ~46

from San Diego, CA

Get Report

Also known as:

Jason M Summa
Jason N Summa

Connected to:

Jason Summa Phones & Addresses

San Diego, CA
Los Angeles, CA
Evanston, IL
Dunmore, PA
18 Decatur St, Cambridge, MA 02139
30 Cambridgepark Dr, Cambridge, MA 02140
Arlington, MA
Seattle, WA
Brookline, MA
University Park, PA

Resumes

Banquet Bartender

view source

Location:

9303 4Th Ave, Orlando, FL 32824

Industry:

Hospitality

Work:

Universal Orlando Resort May 2003 - Jul 2013
Banquet Server
Hard Rock International May 2003 - Jul 2013
Banquet Bartender

Skills:

Bartending
Banquets
Catering
Retail
Photography
Music
Weddings
Hospitality
Food and Beverage

Johnson And Johnson Innovation, Jpal

view source

Location:

1570 Elmwood Ave, Evanston, IL 60201

Industry:

Pharmaceuticals

Work:

Johnson & Johnson
Johnson and Johnson Innovation, Jpal
Janssen Inc.
Director, Clinical Project Scientist, Oncology
Bind Therapeutics 2014 - 2016
Senior Director, Clinical
Bind Therapeutics 2013 - 2014
Director, Clinical
Bind Therapeutics 2011 - 2013
Head of Clinical Operations and Program Manager For Bind-014

Education:

Boston University 2007 - 2010
Master of Business Administration, Masters, Management Penn State University Sep 1995 - 1999
Bachelors, Bachelor of Science, Chemistry

Skills:

Clinical Trials
Biotechnology
Clinical Development
Drug Development
Oncology
Clinical Research
Life Sciences
Fda
Pharmaceutical Industry
Gcp
Project Management
Regulatory Submissions
Ind
Clinical Operations
Drug Discovery
Cross Functional Team Leadership
Chromatography
Ctms
Gmp
Program Management
Strategic Planning
Good Clinical Practice
Clinical Trial Management System
U.s. Food and Drug Administration
Cmc
Pre Clinical Studies
Phase 1
Phase 2

Certifications:

Certification In Applied Project Management
Biotechnology Project Management
Boston University
Massachusetts Biotechnology Council

Us Patents

Inhalable Epinephrine
view source
US Patent:

8415397, Apr 9, 2013
Filed:

Apr 8, 2011
Appl. No.:

13/082626
Inventors:

Richard P. Batycky - Newton MA, US
Giovanni Caponetti - Piacenza, IT
Mariko Childs - Arlington MA, US
Elliot Ehrich - Lincoln MA, US
Karen Fu - Cambridge MA, US
Jeffrey S. Hrkach - Cambridge MA, US
Wen-I Li - Lexington MA, US
Michael M. Lipp - Framingham MA, US
Mei-Ling Pan - Cambridge MA, US
Jason Summa - Arlington MA, US
Assignee:

Civitas Therapeutics, Inc. - Chelsea MA
International Classification:

A61K 9/14
A61K 31/13
A61K 31/135
A61K 31/045
US Classification:

514653, 514669, 514728, 424 46, 424489
Abstract:

The present invention is directed toward particles for delivery of epinephrine to the respiratory system and methods for treating a patient in need of epinephrine. The particles and respirable compositions comprising the particles of the present invention described herein comprise the bioactive agent epinephrine, or a salt thereof, as a therapeutic agent. The particles are preferably formed by spray drying. Preferably, the particles and the respirable compositions are substantially dry and are substantially free of propellents. In a preferred embodiment, the particles have aerodynamic characteristics that permit targeted delivery of epinephrine to the site(s) of action.

Inhalable Epinephrine
view source
US Patent:

20040076588, Apr 22, 2004
Filed:

Jun 26, 2003
Appl. No.:

10/607571
Inventors:

Richard Batycky - Newton MA, US
Giovanni Caponetti - Piacenza, IT
Mariko Childs - Arlington MA, US
Elliot Ehrich - Lincoln MA, US
Karen Fu - Cambridge MA, US
Jeffrey Hrkach - Cambridge MA, US
Wen-I Li - Lexington MA, US
Michael Lipp - Framingham MA, US
Mei-Ling Pan - Cambridge MA, US
Jason Summa - Arlington MA, US
International Classification:

A61L009/04
A61K009/14
A61K031/137
US Classification:

424/046000, 514/649000
Abstract:

The present invention is directed toward particles for delivery of epinephrine to the respiratory system and methods for treating a patient in need of epinephrine. The particles and respirable compositions comprising the particles of the present invention described herein comprise the bioactive agent epinephrine, or a salt thereof, as a therapeutic agent. The particles are preferably formed by spray drying. Preferably, the particles and the respirable compositions are substantially dry and are substantially free of propellents. In a preferred embodiment, the particles have aerodynamic characteristics that permit targeted delivery of epinephrine to the site(s) of action.

Inhalable Epinephrine
view source
US Patent:

20130253065, Sep 26, 2013
Filed:

Mar 6, 2013
Appl. No.:

13/787026
Inventors:

Giovanni Caponetti - Piacenza, IT
Mariko Childs - Arlington MA, US
Elliot Ehrich - Lincoln MA, US
Karen Fu - Lexington MA, US
Jeffrey S. Hrkach - Lexington MA, US
Wen-I Li - Lexington MA, US
Michael M. Lipp - Framingham MA, US
Mei-Ling Pan - Cambridge MA, US
Jason Summa - Cambridge MA, US
Assignee:

Civitas Therapeutics, Inc. - Chelsea MA
International Classification:

A61K 9/00
A61K 31/137
US Classification:

514653
Abstract:

The present invention is directed toward particles for delivery of epinephrine to the respiratory system and methods for treating a patient in need of epinephrine. The particles and respirable compositions comprising the particles of the present invention described herein comprise the bioactive agent epinephrine, or a salt thereof, as a therapeutic agent. The particles are preferably formed by spray drying. Preferably, the particles and the respirable compositions are substantially dry and are substantially free of propellents. In a preferred embodiment, the particles have aerodynamic characteristics that permit targeted delivery of epinephrine to the site(s) of action.

Methods Of Treating Cancers With Therapeutic Nanoparticles
view source
US Patent:

20170151181, Jun 1, 2017
Filed:

Apr 17, 2015
Appl. No.:

15/294061
Inventors:

- New York NY, US
Jason Summa - Cambridge MA, US
Assignee:

Pfizer Inc. - New York NY
International Classification:

A61K 9/51
A61K 9/00
A61K 31/337
Abstract:

The present disclosure relates in part to methods of treating cancers having a mutation in a Ras gene in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a nanoparticle composition, wherein the nanoparticle composition comprises nanoparticles.

Inhalable Epinephrine
view source
US Patent:

20170119699, May 4, 2017
Filed:

Dec 23, 2016
Appl. No.:

15/389614
Inventors:

- Chelsea MA, US
Giovanni Caponetti - Piacenza, IT
Mariko Childs - Arlington MA, US
Elliot Ehrich - Boston MA, US
Karen Fu - Lexington MA, US
Jeffrey S. Hrkach - Lexington MA, US
Wen-I Li - Lexington MA, US
Michael M. Lipp - Framingham MA, US
Mei-Ling Pan - Cambridge MA, US
Jason Summa - Cambridge MA, US
International Classification:

A61K 31/137
A61M 15/00
A61K 9/00
Abstract:

The present invention is directed toward particles for delivery of epinephrine to the respiratory system and methods for treating a patient in need of epinephrine. The particles and respirable compositions comprising the particles of the present invention described herein comprise the bioactive agent epinephrine, or a salt thereof, as a therapeutic agent. The particles are preferably formed by spray drying. Preferably, the particles and the respirable compositions are substantially dry and are substantially free of propellents. In a preferred embodiment, the particles have aerodynamic characteristics that permit targeted delivery of epinephrine to the site(s) of action.

Nanoparticles Comprising Docetaxel For Treating Cancers Having A K-Ras Mutation
view source
US Patent:

20170042855, Feb 16, 2017
Filed:

Apr 17, 2015
Appl. No.:

15/304345
Inventors:

- Cambridge MA, US
Jason Summa - Cambridge MA, US
International Classification:

A61K 31/337
A61K 9/16
A61K 45/06
A61K 9/00
Abstract:

The present disclosure relates in part to methods of treating cancers having a mutation in a Ras gene in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a nanoparticle composition, wherein the nanoparticle composition comprises nanoparticles.

Inhalable Epinephrine
view source
US Patent:

20150094378, Apr 2, 2015
Filed:

May 1, 2014
Appl. No.:

14/267401
Inventors:

- Chelsea MA, US
Giovanni Caponetti - Piacenza, IT
Mariko Childs - Arlington MA, US
Elliot Ehrich - Lincoln MA, US
Karen Fu - Lexington MA, US
Jeffrey S. Hrkach - Lexington MA, US
Wen-I Li - Lexington MA, US
Michael M. Lipp - Framingham MA, US
Mei-Ling Pan - Cambridge MA, US
Jason Summa - Cambridge MA, US
Assignee:

Civitas Therapeutics, Inc. - Chelsea MA
International Classification:

A61K 31/137
A61K 9/00
US Classification:

514653
Abstract:

The present invention is directed toward particles for delivery of epinephrine to the respiratory system and methods for treating a patient in need of epinephrine. The particles and respirable compositions comprising the particles of the present invention described herein comprise the bioactive agent epinephrine, or a salt thereof, as a therapeutic agent. The particles are preferably formed by spray drying. Preferably, the particles and the respirable compositions are substantially dry and are substantially free of propellents. In a preferred embodiment, the particles have aerodynamic characteristics that permit targeted delivery of epinephrine to the site(s) of action.